Anita V Hill
Overview
Explore the profile of Anita V Hill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kibirige D, Katte J, Hill A, Sekitoleko I, Lumu W, Knupp J, et al.
BMJ Open Diabetes Res Care
. 2024 Aug;
12(4).
PMID: 39209773
Introduction: We undertook phenotypic characterization of early-onset and late-onset type 2 diabetes (T2D) in adult black African and white European populations with recently diagnosed T2D to explore ethnic differences in...
2.
Thomas N, Hill A, Dayan C, Oram R, McDonald T, Shields B, et al.
Diabetes Care
. 2023 Feb;
46(6):1156-1163.
PMID: 36802355
Objective: To determine whether presentation, progression, and genetic susceptibility of robustly defined adult-onset type 1 diabetes (T1D) are altered by diagnosis age. Research Design And Methods: We compared the relationship...
3.
Eason R, Thomas N, Hill A, Knight B, Carr A, Hattersley A, et al.
Diabetes Care
. 2022 Oct;
45(12):2844-2851.
PMID: 36205650
Objective: Recent joint American Diabetes Association and European Association for the Study of Diabetes guidelines recommend routine islet autoantibody testing in all adults newly diagnosed with type 1 diabetes. We...
4.
Rodgers L, Hill A, Dennis J, Craig Z, May B, Hattersley A, et al.
BMC Med
. 2021 Aug;
19(1):184.
PMID: 34412655
Background: Type 2 diabetes (T2D) is common and increasing in prevalence. It is possible to prevent or delay T2D using lifestyle intervention programmes. Entry to these programmes is usually determined...
5.
Thomas N, Lynam A, Hill A, Weedon M, Shields B, Oram R, et al.
Diabetologia
. 2019 Apr;
62(7):1167-1172.
PMID: 30969375
Aims/hypothesis: Late-onset type 1 diabetes can be difficult to identify. Measurement of endogenous insulin secretion using C-peptide provides a gold standard classification of diabetes type in longstanding diabetes that closely...
6.
Dennis J, Shields B, Hill A, Knight B, McDonald T, Rodgers L, et al.
Diabetes Care
. 2018 Feb;
41(4):705-712.
PMID: 29386249
Objective: A precision approach to type 2 diabetes therapy would aim to target treatment according to patient characteristics. We examined if measures of insulin resistance and secretion were associated with...
7.
Hope S, Knight B, Shields B, Hill A, Choudhary P, Strain W, et al.
Diabetologia
. 2017 Oct;
61(1):66-74.
PMID: 28983693
Aims/hypothesis: The aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk in insulin-treated type 2 diabetes. Methods: We compared...
8.
Jones A, McDonald T, Shields B, Hill A, Hyde C, Knight B, et al.
Diabetes Care
. 2015 Aug;
39(2):250-7.
PMID: 26242184
Objective: To assess whether clinical characteristics and simple biomarkers of β-cell failure are associated with individual variation in glycemic response to GLP-1 receptor agonist (GLP-1RA) therapy in patients with type...
9.
Shields B, Knight B, Hill A, Hattersley A, Vaidya B
J Clin Endocrinol Metab
. 2013 Nov;
98(12):E1941-5.
PMID: 24217906
Context: Increasing numbers of women are being treated with l-thyroxine in pregnancy for mild thyroid dysfunction because of its association with impaired neuropsychological development in their offspring and other adverse...